The Generics Bulletin Top 50, Part Two: Mid-Table Movements See Firms Jostle For Position
Some Companies Climb As Others Slip Down Rankings
Medium-sized generics and biosimilars players have seen ups and downs over the past year, with some changes to the order of these mid-table players seen as we continue to work our way through Generics Bulletin’s annual Top 50.
